CompletedPHASE2, PHASE3NCT00128466
Treatment and Diagnosis of Plague
Studying Plague
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centers for Disease Control and Prevention
- Principal Investigator
- Kevin Griffith, MD, MPHCenters for Disease Control and Prevention
- Intervention
- gentamicin(drug)
- Enrollment
- 114 target
- Eligibility
- 2 years · All sexes
- Timeline
- 2004 – 2007
Study locations (1)
- Ministry of Health, Antananarivo, Antananarivo, Madagascar
Collaborators
Food and Drug Administration (FDA) · Ministry of Health, Madagascar · Ministry of Health, Uganda
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00128466 on ClinicalTrials.govOther trials for Plague
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07207408Immunogenicity, Safety, and Tolerability of rF1V-1018 Vaccine in Adults 18 to 55 Years of AgeDynavax Technologies Corporation
- RECRUITINGPHASE1NCT06943378Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy AdultsJust-Evotec Biologics
- RECRUITINGNANCT06083649The Dental Care Revolution: Health Education Using AI or Humanized Counseling on Plague Control and Periodontal Treatment Outcome in Patients With Periodontal DiseaseKaohsiung Medical University Chung-Ho Memorial Hospital